Covered recipient · General Payments record
SELINA LUGER
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2024
$97,514.54
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,410.75 | 4 |
| Travel and Lodging | $13,262.37 | 10 |
| Food and Beverage | $417.56 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $25,953.41 | 14 |
| Daiichi Sankyo Inc. | $3,019.77 | 4 |
| Astellas Pharma US Inc | $117.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $686.00 | 05/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115885423 | CMS |
| Amgen Inc. | $44.51 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115885430 | CMS |
| Amgen Inc. | $71.55 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115885436 | CMS |
| Amgen Inc. | $304.84 | 06/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885478 | CMS |
| Amgen Inc. | $650.98 | 06/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885486 | CMS |
| Amgen Inc. | $7,000.00 | 06/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885493 | CMS |
| Amgen Inc. | $854.59 | 06/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885496 | CMS |
| Amgen Inc. | $12.93 | 08/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885439 | CMS |
| Amgen Inc. | $36.10 | 08/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885442 | CMS |
| Amgen Inc. | $9,562.00 | 08/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115885446 | CMS |
| Amgen Inc. | $2,942.23 | 08/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885451 | CMS |
| Amgen Inc. | $734.30 | 08/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885462 | CMS |
| Amgen Inc. | $309.38 | 08/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115885456 | CMS |
| Amgen Inc. | $2,744.00 | 11/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115885470 | CMS |
| Astellas Pharma US Inc | $117.50 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139327740 | CMS |
| Daiichi Sankyo Inc. | $417.02 | 01/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089450210 | CMS |
| Daiichi Sankyo Inc. | $54.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089450214 | CMS |
| Daiichi Sankyo Inc. | $2,418.75 | 07/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089450208 | CMS |
| Daiichi Sankyo Inc. | $130.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089450212 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.